Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 9.4B | 9.6B | 9.3B |
Cost of revenue | 5.9B | 5.7B | 5.7B | 5.5B |
Gross profit | 3.2B | 3.7B | 3.8B | 3.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.1B | 1.2B | 1.1B | 1.3B |
Operating income | 1.8B | 2.2B | 2.4B | 2.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 45.9M | 46.5M | 48.5M | 48.9M |
Other income expense | — | — | — | — |
Pretax income | 2.2B | 2.6B | 3.0B | 2.5B |
Tax provision | 490.3M | 568.4M | 692.8M | 683.2M |
Net income | 1.7B | 2.0B | 2.3B | 1.8B |
Basic EPS | — | 32.0 | 36.8 | 29.6 |
Diluted EPS | — | 31.9 | 36.8 | 29.6 |
Basic average shares | — | 62.3M | 62.3M | 62.3M |
Diluted average shares | — | 62.3M | 62.3M | 62.3M |
EBITDA | 2.5B | 2.9B | 3.3B | 2.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |